eCite Digital Repository

Advanced resistance studies identify two discrete mechanisms in Staphylococcus aureus to overcome antibacterial compounds that target biotin protein ligase


Hayes, AJ and Satiaputra, J and Sternicki, LM and Paparella, AS and Feng, ZK and Lee, KJ and Blanco-Rodriguez, B and Tieu, W and Eijkelkamp, BA and Shearwin, KE and Pukala, TL and Abell, AD and Booker, GW and Polyak, SW, Advanced resistance studies identify two discrete mechanisms in Staphylococcus aureus to overcome antibacterial compounds that target biotin protein ligase, Antibiotics, 9, (4) Article 165. ISSN 2079-6382 (2020) [Refereed Article]


Copyright Statement

Copyright 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (

Official URL:

DOI: doi:10.3390/antibiotics9040165


Biotin protein ligase (BPL) inhibitors are a novel class of antibacterial that target clinically important methicillin-resistant Staphylococcus aureus (S. aureus). In S. aureus, BPL is a bifunctional protein responsible for enzymatic biotinylation of two biotin-dependent enzymes, as well as serving as a transcriptional repressor that controls biotin synthesis and import. In this report, we investigate the mechanisms of action and resistance for a potent anti-BPL, an antibacterial compound, biotinyl-acylsulfamide adenosine (BASA). We show that BASA acts by both inhibiting the enzymatic activity of BPL in vitro, as well as functioning as a transcription co-repressor. A low spontaneous resistance rate was measured for the compound (<10-9) and whole-genome sequencing of strains evolved during serial passaging in the presence of BASA identified two discrete resistance mechanisms. In the first, deletion of the biotin-dependent enzyme pyruvate carboxylase is proposed to prioritize the utilization of bioavailable biotin for the essential enzyme acetyl-CoA carboxylase. In the second, a D200E missense mutation in BPL reduced DNA binding in vitro and transcriptional repression in vivo. We propose that this second resistance mechanism promotes bioavailability of biotin by derepressing its synthesis and import, such that free biotin may outcompete the inhibitor for binding BPL. This study provides new insights into the molecular mechanisms governing antibacterial activity and resistance of BPL inhibitors in S. aureus.

Item Details

Item Type:Refereed Article
Keywords:antimicrobial resistance, Gram-positive bacteria, Staphylococcus aureus, advanced resistance studies, biotin, biotin protein ligase, BirA, novel antibacterials
Research Division:Chemical Sciences
Research Group:Analytical chemistry
Research Field:Separation science
Objective Division:Health
Objective Group:Clinical health
Objective Field:Clinical health not elsewhere classified
UTAS Author:Feng, ZK (Mr Zikai Feng)
ID Code:143026
Year Published:2020
Web of Science® Times Cited:2
Deposited By:Pharmacy
Deposited On:2021-02-23
Last Modified:2021-04-09
Downloads:17 View Download Statistics

Repository Staff Only: item control page